Data / Federal awards / NAICS 541714 / PPD DEVELOPMENT LP
PPD DEVELOPMENT LP: 45 federal contract awards, $182.7 million obligated (FY2024 to FY2027)
PPD DEVELOPMENT LP (UEI ZANENSW6C665), Wilmington, NC, received 45 federal prime contract awards with $182.7 million obligated in fiscal years 2024 to 2027, from 3 agencies under 7 NAICS codes. Its largest buyer is Department of Health and Human Services ($182.8 million) and its largest code is NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology).
SpecStream is the live web data engine for teams and agents. It reads every federal contract award on USAspending.gov and every open opportunity on SAM.gov, and this page is that reading. Ask for the awards in your niche and the winners, agencies, values and recompetes arrive in your sheet, CRM, Slack or agent as they are reported.
- UEI
- ZANENSW6C665
- Parent organization
- PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
- Location
- Wilmington, NC
- Business size
- Other Than Small Business
- Contract awards
- 45
- Obligated
- $182.7 million
- First action in window
- 2023-10-11
- Latest action
- 2026-09-29
Where the work is
NAICS codes, with the other winners in each.
| NAICS | Industry | Awards | Obligated |
|---|---|---|---|
| 541714 | Research and Development in Biotechnology (except Nanobiotechnology) | 13 | $197.2 million |
| 541715 | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | 14 | $23.2 million |
| 541720 | Research and Development in the Social Sciences and Humanities | 1 | $1.3 million |
| 541711 | Research and Development in Biotechnology | 3 | $828,872 |
| 541990 | All Other Professional, Scientific, and Technical Services | 3 | $-8,155 |
| 541690 | Other Scientific and Technical Consulting Services | 2 | $-428,033 |
| 541712 | Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) | 9 | $-39,368,022 |
Buying agencies
| Agency | Awards | Obligated |
|---|---|---|
| Department of Health and Human Services | 41 | $182.8 million |
| General Services Administration | 1 | $2,500 |
| Department of Defense | 3 | $-83,417 |
Obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2024 | $139.7 million |
| FY2025 | $-7,480,083 |
| FY2026 | $50.5 million |
Contract awards
All 45 awards in fiscal years 2024 to 2027.
| Award ID | Agency | Type | NAICS | What it buys | Obligated in window | Award value | Starts | Ends | Place of performance | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 75A50124C00001 | Department of Health and Human Services | Definitive Contract | 541714 | BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY | $117,399,278 | $117,399,278 | December 15, 2023 | September 30, 2030 | Wilmington, NC | usaspending.gov |
| 75N93024F00001 | Department of Health and Human Services | Delivery Order | 541714 | NIAID CLINICAL SITE MONITORING (NCSM) | $73,196,564 | $73,196,564 | February 1, 2024 | January 31, 2027 | Wilmington, NC | usaspending.gov |
| 75N93024F00002 | Department of Health and Human Services | Delivery Order | 541714 | COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) | $26,101,778 | $26,101,778 | August 15, 2024 | August 14, 2027 | Wilmington, NC | usaspending.gov |
| 75N93022C00014 | Department of Health and Human Services | Definitive Contract | 541715 | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) CLINICAL SITE MONITORING CENTER (CSMC) | $21,966,386 | $36,391,559 | June 30, 2022 | June 29, 2027 | Wilmington, NC | usaspending.gov |
| 75N93022C00001 | Department of Health and Human Services | Definitive Contract | 541714 | REGULATORY MANAGEMENT CENTER (RMC) | $9,144,498 | $17,426,404 | November 1, 2021 | October 31, 2026 | Wilmington, NC | usaspending.gov |
| 75N93026F00001 | Department of Health and Human Services | Delivery Order | 541714 | DAIDS MONITORING FOR 1 PHASE III STUDY: A5300B/I2003B (PHOENIX) | $3,092,829 | $3,092,829 | December 15, 2025 | December 14, 2026 | Wilmington, NC | usaspending.gov |
| 75N95024F00001 | Department of Health and Human Services | Delivery Order | 541712 | FIRST IN HUMAN RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED SINGLE ASCENDING DOSE (SAD) PHASE I STUDY | $2,773,098 | $2,773,098 | July 8, 2016 | June 30, 2026 | Wilmington, NC | usaspending.gov |
| 75N98026F00001 | Department of Health and Human Services | Delivery Order | 541712 | TASK ORDER AWARD- PHASE I CLINICAL TRIALS FOR THE DEVELOPMENT OF NEUROTHERAPEUTICS- DTI-117 IN HEALTHY VOLUNTEERS/SAD AND MAD CT | $2,016,831 | $2,016,831 | June 29, 2026 | April 28, 2027 | Wilmington, NC | usaspending.gov |
| 75N93019F00131 | Department of Health and Human Services | Delivery Order | 541711 | TO PROVIDE MONITORING SERVICES FOR ONE (1) PHASE III CLINICAL TRIAL, A5300B/PHOENIX | $1,301,001 | $5,696,077 | April 15, 2019 | December 14, 2025 | Wilmington, NC | usaspending.gov |
| 75F40124C00134 | Department of Health and Human Services | Definitive Contract | 541720 | BAA-FY24C3CP5-UNDERSTANDING HETEROGENEITY IN PREFERENCES FOR CLINICAL TRIAL PARTICIPATION IN DIVERSE PATIENT POPULATIONS. | $1,299,218 | $1,299,218 | September 24, 2024 | November 22, 2027 | Wilmington, NC | usaspending.gov |
| 75F40124C00117 | Department of Health and Human Services | Definitive Contract | 541714 | FDABAA-24-00123, REF # FY24C1EP6, CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME PATIENT-REPORTED OUTCOME (PRO) BURDEN MEASURE | $724,461 | $724,461 | September 11, 2024 | July 15, 2027 | Wilmington, NC | usaspending.gov |
| 75N93022F00001 | Department of Health and Human Services | Delivery Order | 541715 | TASK ORDER 75N93022F00001 BASE AWARD | $549,285 | $905,501 | January 14, 2022 | January 13, 2027 | Wilmington, NC | usaspending.gov |
| 75N95022C00036 | Department of Health and Human Services | Definitive Contract | 541990 | CLINICAL RESEARCH AND STUDY MONITORING SUPPORT FOR NIMH STUDIES | $437,516 | $1,226,376 | September 28, 2022 | May 15, 2025 | Wilmington, NC | usaspending.gov |
| 75N95024F00001 | Department of Health and Human Services | Delivery Order | 541715 | REGULATORY CONSULTING ASSISTANCE FOR MEDICAL DEVICE DEVELOPER. RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. PRE-S | $370,621 | $370,621 | April 9, 2024 | April 8, 2029 | Wilmington, NC | usaspending.gov |
| 75N95024F00001 | Department of Health and Human Services | Delivery Order | 541715 | RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. CLINICAL STUDY PROTOCOL DEVELOPMENT. TASK ORDER 02. 06/17/2024 - 06/ | $324,420 | $324,420 | June 17, 2024 | June 16, 2029 | Wilmington, NC | usaspending.gov |
| 75N95024F00002 | Department of Health and Human Services | Delivery Order | 541712 | PHASE I RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS | $305,772 | $305,772 | July 15, 2024 | June 30, 2026 | Wilmington, NC | usaspending.gov |
| 75F40123C00198 | Department of Health and Human Services | Definitive Contract | 541714 | ASSESSING CLINICAL SITE READINESS: A FRAMEWORK TO SUPPORT ENROLLMENT OF UNDER-REPRESENTED MINORITIES IN MEDICAL DEVICE CLINICAL TRIALS (FY23 | $44,810 | $235,056 | September 27, 2023 | July 20, 2024 | Wilmington, NC | usaspending.gov |
| 75N95023F00001 | Department of Health and Human Services | Delivery Order | 541715 | REGULATORY CONSULTING ASSISTANCE FOR MEDICAL DEVICE DEVELOPER. RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. TASK | $31,102 | $63,603 | September 15, 2023 | December 31, 2024 | Wilmington, NC | usaspending.gov |
| 75N98026D00092 | Department of Health and Human Services | IDC | 541714 | VACCINE MANUFACTURING SERVICES FOR INFECTIOUS DISEASES | $10,000 | $48,000,000 | September 25, 2026 | usaspending.gov | ||
| 75N95025F00001 | Department of Health and Human Services | Delivery Order | 541715 | TASK ORDER75N95025F00001 TO4 BLUEPRINT MEDTECH PREPARATION OF PRE-SUBMISSION SUPPORT FOR PILOT PARTICIPANT. | $5,334 | $5,334 | December 20, 2024 | December 19, 2025 | Wilmington, NC | usaspending.gov |
| 47QRCA25DU259 | General Services Administration | IDC | 541690 | ONE ACQUISITION SOLUTION FOR INTEGRATED SERVICES PLUS (OASIS+) UNRESTRICTED MULTIPLE AGENCY CONTRACT (MAC) | $2,500 | $999,999,999,999 | December 17, 2024 | usaspending.gov | ||
| 75A50123C00045 | Department of Health and Human Services | Definitive Contract | 541715 | ADVANCED RESEARCH AND DEVELOPMENT ACTIVITIES FOR NOVEL IMMUNOGENICITY ASSAYS AND SAMPLE COLLECTION TECHNOLOGIES AS PART OF BARDA?S CONTINUIN | $0 | $126,485,055 | September 29, 2023 | September 28, 2029 | Wilmington, NC | usaspending.gov |
| 75N93021D00035 | Department of Health and Human Services | IDC | 541714 | COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS | $0 | $545,452,906 | September 1, 2021 | usaspending.gov | ||
| 75N93022D00017 | Department of Health and Human Services | IDC | 541715 | EARLY PHASE CLINICAL TRIAL UNITS (EPCTU) | $0 | $346,610,277 | January 14, 2022 | usaspending.gov | ||
| 75N95023D00011 | Department of Health and Human Services | IDC | 541715 | RESEARCH AND DEVELOPMENT FOR CLINICAL STUDIES IN THE BLUEPRINT MEDTECH. ORDERING PERIOD: 09/01/2023 - 8/31/2028. (BPMT) INITIATIVE. | $0 | $49,900,000 | September 1, 2023 | usaspending.gov | ||
| 75A50121P00004 | Department of Health and Human Services | Purchase Order | 541715 | ESTABLISHMENT OF HIGH THROUGHPUT SARS-COV-2 BINDING ANTIBODY IMMUNOASSAY CAPABILITY AND TESTING OF HUMAN SERUM SAMPLES | $0 | $1,422,550 | November 16, 2020 | November 22, 2021 | Wilmington, NC | usaspending.gov |
| 75N93023F00001 | Department of Health and Human Services | Delivery Order | 541715 | EPCTU | $0 | $2,791,811 | June 29, 2023 | January 31, 2026 | Wilmington, NC | usaspending.gov |
| 75N95022D00020 | Department of Health and Human Services | IDC | 541715 | CONTRACT RESEARCH ORGANIZATION (CRO) SUPPORT FOR BLUEPRINT MEDTECH (BPMT) REGULATORY AFFAIRS SUPPORT AND RELATED SERVICES. ORDERING PERIOD: | $0 | $24,000,000 | September 22, 2022 | usaspending.gov | ||
| HHSN271201800007I | Department of Health and Human Services | IDC | 541715 | SUPPORT DPI DRUG DEVELOPMENT PROGRAMS BY (1) DEVELOPING AND VALIDATING SENSITIVE AND BIOANALYTICAL METHODS TO QUANTIFY CONCENTRATIONS OF NOV | $0 | $3,912,150 | March 26, 2018 | usaspending.gov | ||
| HT001122D0040 | Department of Defense | IDC | 541714 | OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT | $0 | $10,000,000,000 | June 20, 2022 | usaspending.gov | ||
| 75N93021F00001 | Department of Health and Human Services | Delivery Order | 541714 | COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS | $-2,000 | $0 | September 1, 2021 | August 31, 2022 | Bethesda, MD | usaspending.gov |
| 75N92019C00005 | Department of Health and Human Services | Definitive Contract | 541990 | ACQUISITION TITLE: CLINICAL SITE AND STUDY MONITORING SUPPORT SERVICES FOR THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE'S HYPERTENSION OUTC | $-12,975 | $654,561 | April 25, 2019 | July 25, 2023 | Bethesda, MD | usaspending.gov |
| 0011 | Department of Defense | Delivery Order | 541712 | FDA REGULATORY COMPLIANCE TRAINING | $-30,029 | $1,345,959 | October 25, 2017 | October 24, 2022 | Wilmington, NC | usaspending.gov |
| 75N95018F00002 | Department of Health and Human Services | Delivery Order | 541712 | IGF::OT::IGF PHASE I CLINICAL TRIALS FOR DEVELOPMENT OF NEUROTHERAPEUTICS TASK ORDER NO. 2 - PETRUKIN | $-33,049 | $1,737,263 | June 1, 2018 | August 30, 2020 | Wilmington, NC | usaspending.gov |
| W81XWH18F0195 | Department of Defense | Delivery Order | 541712 | HIV COHORT STUDY | $-53,388 | $516,111 | June 13, 2018 | October 13, 2022 | Thailand | usaspending.gov |
| 75N95018F00001 | Department of Health and Human Services | Delivery Order | 541715 | PPD DEVELOPMENT LP:1106692 [18-007540] | $-78,400 | $347,500 | September 24, 2018 | November 24, 2020 | Wilmington, NC | usaspending.gov |
| HHSN272201200002C | Department of Health and Human Services | Definitive Contract | 541711 | R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH) | $-96,445 | $21,947,372 | November 1, 2011 | October 31, 2021 | Wilmington, NC | usaspending.gov |
| 75N95019F00089 | Department of Health and Human Services | Delivery Order | 541712 | BUCKPITT-PHASE I SINGLE ASCENDING DOSE STUDY-BPN-19186 (EC5026) PROTOCOL DEVELOPMENT AND FINALIZATION AND DATABASE BUILD AND BIOANALYTICAL M | $-272,785 | $1,820,177 | July 1, 2019 | March 10, 2025 | Wilmington, NC | usaspending.gov |
| HHSN272201200004C | Department of Health and Human Services | Definitive Contract | 541711 | TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER | $-375,684 | $27,036,076 | December 16, 2011 | August 20, 2026 | Wilmington, NC | usaspending.gov |
| 75D30121C11269 | Department of Health and Human Services | Definitive Contract | 541690 | TBTC MONITORING | $-430,533 | $2,054,175 | June 10, 2021 | June 27, 2024 | Wilmington, NC | usaspending.gov |
| HHSN271201700007A | Department of Health and Human Services | Purchase Order | 541990 | IGF::OT::IGF PPD DEVELOPMENT SITE&STUDY MONITORING | $-432,696 | $696,693 | May 12, 2017 | May 25, 2022 | Wilmington, NC | usaspending.gov |
| HHSN272201700004C | Department of Health and Human Services | Definitive Contract | 541712 | IGF::OT::IGF NIAID CLINICAL SITE MONITORING | $-10,609,694 | $135,144,719 | January 31, 2017 | January 31, 2024 | Wilmington, NC | usaspending.gov |
| 75N93022F00001 | Department of Health and Human Services | Delivery Order | 541714 | COVID 19. THIS TASK ORDER IS TO PROVIDE COMPREHENSIVE/FULL CLINICAL TRIAL MANAGEMENT SUPPORT SERVICES TO THE ONGOING ACTIV-2 CLINICAL TRIAL. | $-13,963,728 | $34,618,532 | May 6, 2022 | November 5, 2022 | Wilmington, NC | usaspending.gov |
| 75N93022F00002 | Department of Health and Human Services | Delivery Order | 541714 | "COVID 19"COMPLETION OF ACTIV 2 STUDY | $-18,500,000 | $64,031,927 | November 6, 2022 | August 31, 2025 | Wilmington, NC | usaspending.gov |
| HHSN272201700078C | Department of Health and Human Services | Definitive Contract | 541712 | IGF::OT::IGF NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS) | $-33,464,778 | $329,835,681 | August 14, 2017 | August 14, 2024 | Wilmington, NC | usaspending.gov |
Also on SpecStream
- All recipients under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- All recipients under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- All recipients under NAICS 541720 Research and Development in the Social Sciences and Humanities
- Open opportunities under NAICS 541714
- Open opportunities under NAICS 541715
- Open opportunities under NAICS 541720
Updated October 6, 2026. Read from USAspending.gov. Public U.S. federal spending data (U.S. Department of the Treasury). Obligations are the contract actions dated in fiscal years 2024 to 2027 of the USAspending.gov award archive of 2026-10-06; a contract's total value is its current value as USAspending reports it, including earlier years. Recipients are matched on their SAM.gov UEI, never on the name, and are shown as the government prints them. Sole proprietorships and opted-out entities count in the totals and are not named. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.